ARTICLE | Clinical News
Tobramycin inhalation solution regulatory update
November 4, 2013 8:00 AM UTC
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA, Petah Tikva, Israel) said FDA approved its generic version of TOBI from Novartis to treat chronic pulmonary infection caused by Pseudomonas aeruginosa ...